Pharmacists, Pharmacies, and Manufacturers, Wholesalers, and Distributors (216-RICR-40-15-1)

216-RICR-40-15-1 PROPOSED RULE

Title 216 Department of Health
Chapter 40 Professional Licensing and Facility Regulation
Subchapter 15 Pharmacy
Part 1 Pharmacists, Pharmacies, and Manufacturers, Wholesalers, and Distributors (216-RICR-40-15-1)
Type of Filing Amendment
Regulation Status Proposed
Filing Notice Date 10/28/2025
Public Comment Dates 10/28/2025 to 11/27/2025

Regulation Authority:

R.I. Gen. Laws § 5-19.1-5(6)
R.I. Gen. Laws § 27-18-93(e)
R.I. Gen. Laws § 23-25.6-7
R.I. Gen. Laws Chapter 5-19.2

Purpose and Reason:

The Department is amending this rule to include the following:

  • A pharmaceutical redistribution program utilizing donated drugs by January 1, 2023 as required by R.I. Pub. Law 22-402.
  • Allowing licensed pharmacists to prescribe, dispense, and administer medications for Human Immunodeficiency Virus (HIV) Preexposure (PrEP) and Post-exposure (PEP) Prophylaxis pursuant to R.I. Gen. Laws § 27-18-93.
  • Revisions to the Collaborative Practice Agreement policies
  • Updates to wording regarding staffing requirements
  • Updates to wording regarding compounding to reflect updates to the language in the USP


Revisions to R.I. Gen. Laws § 5-19.1-11, 5-19.1-15, 5-19.1-16, and 5-19.1-20 which implements the following changes:

  • Pharmacist licenses will be valid for a period of two years as R.I. Gen. Laws § 5-19.1-20 states that the renewal fee is to be paid biennially. RIDOH lengthened the licensing period to correspond to the change in the statute.
  • Pharmacy intern licenses will be valid for a minimum of five years.
  • Pharmacy technician licenses will be valid for a minimum of two years.

0

Comment(s) Received*

The agency is not accepting online public comments for this filing.To submit a comment, please contact the agency directly at the addresses listed on the Notice of Proposed Rulemaking.

* This count refers to the total comment submissions received on this document, as of 11:59 PM yesterday.
Note: Agencies review all submissions; however, some agencies may choose to withhold certain submissions such as those containing private or sensitive information, profane or threatening language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and the actual number of comments displayed on this page. For specific information about a comment you submitted, please contact the agency directly.